---
title: "Eslicarbazepine Acetate - Epilepsies, Partial"
sidebar: mydoc_sidebar
permalink: db09119-mesh-d004828-1.html
toc: false 
---


Path ID: `DB09119_MESH_D004828_1`
{% include image.html url="images/db09119-mesh-d004828-1.png" file="db09119-mesh-d004828-1.png" alt="db09119-mesh-d004828-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C416835">MESH:C416835 </a> | eslicarbazepine acetate | Drug |
| <a href="https://identifiers.org/MESH:C571001">MESH:C571001 </a> | eslicarbazepine | Drug |
| <a href="https://identifiers.org/InterPro:IPR001696">InterPro:IPR001696 </a> | Voltage gated sodium channel, alpha subunit | GeneFamily |
| <a href="https://identifiers.org/GO:0035725">GO:0035725 </a> | sodium ion transmembrane transport | BiologicalProcess |
| <a href="https://identifiers.org/GO:0019228">GO:0019228 </a> | neuronal action potential | BiologicalProcess |
| <a href="https://identifiers.org/HP:0011097">HP:0011097 </a> | Epileptic spasm | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D004828">MESH:D004828 </a> | Epilepsies, Partial | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Eslicarbazepine Acetate | HAS METABOLITE | Eslicarbazepine |
| Eslicarbazepine | DECREASES ACTIVITY OF | Voltage Gated Sodium Channel, Alpha Subunit |
| Voltage Gated Sodium Channel, Alpha Subunit | POSITIVELY REGULATES | Sodium Ion Transmembrane Transport |
| Sodium Ion Transmembrane Transport | REGULATES | Neuronal Action Potential |
| Neuronal Action Potential | CONTRIBUTES TO | Epileptic Spasm |
| Epileptic Spasm | POSITIVELY CORRELATED WITH | Epilepsies, Partial |
|---------|-----------|---------|

Comment: The antiseizure mechanism of action based on the voltage sodium channels is not a consensus (https://en.wikipedia.org/wiki/Eslicarbazepine_acetate#Mechanism_of_action). The drug could also bind to calcium channels (https://go.drugbank.com/drugs/DB09119#mechanism-of-action). Note that the protein target listed in DrugBank (https://go.drugbank.com/drugs/DB09119#BE0005793) does not seem to be involved in epilepsy, but rather in inflammation and pain.

Reference: 
  - [https://pubchem.ncbi.nlm.nih.gov/compound/179344#section=Pharmacology-and-Biochemistry](https://pubchem.ncbi.nlm.nih.gov/compound/179344#section=Pharmacology-and-Biochemistry)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL87992/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL87992/)
